Murray Mark Anthony

CIK 00017914431 companyPRINCETON, NJ

Transactions

Companies

Filings

CIK

0001791443

Recent Transactions

14 trades

Disposition to Issuer
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−3,573→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−65,787→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−5,359→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−15,885→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−98,604→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2023-01-03−5,199→ 0 total
Disposition to Issuer
Oyster Point Pharma, Inc.
Common Stock
2023-01-03−118,513→ 3,573 total
Award
Oyster Point Pharma, Inc.
Common Stock
2022-06-06+3,573→ 122,086 total
Award
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2022-06-06+5,359→ 5,359 total
Award
Oyster Point Pharma, Inc.
Common Stock
2021-06-07+3,466→ 118,513 total
Award
Oyster Point Pharma, Inc.
Stock Option (Right to Buy)
2021-06-07+5,199→ 5,199 total
Award
Oyster Point Pharma, Inc.
Common Stock
2020-06-08+6,600→ 115,047 total
Conversion
Oyster Point Pharma, Inc.
Series A Convertible Preferred Stock
2019-11-04−106,517→ 0 total
Conversion
Oyster Point Pharma, Inc.
Common Stock, par value $0.001 per share
2019-11-04+106,517→ 108,447 total

C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109

PRINCETON, NJ, 08540